GO:0006260 | DNA replication | 15.38% (22/143) | 4.03 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 16.08% (23/143) | 3.0 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 12.59% (18/143) | 3.58 | 0.0 | 0.0 |
GO:0006261 | DNA-dependent DNA replication | 11.19% (16/143) | 3.92 | 0.0 | 0.0 |
GO:0006479 | protein methylation | 11.89% (17/143) | 3.51 | 0.0 | 0.0 |
GO:0008213 | protein alkylation | 11.89% (17/143) | 3.51 | 0.0 | 0.0 |
GO:0016570 | histone modification | 12.59% (18/143) | 3.31 | 0.0 | 0.0 |
GO:0061647 | histone H3-K9 modification | 9.79% (14/143) | 3.92 | 0.0 | 0.0 |
GO:0051567 | histone H3-K9 methylation | 9.79% (14/143) | 3.92 | 0.0 | 0.0 |
GO:0018022 | peptidyl-lysine methylation | 10.49% (15/143) | 3.64 | 0.0 | 0.0 |
GO:0034968 | histone lysine methylation | 10.49% (15/143) | 3.65 | 0.0 | 0.0 |
GO:0016571 | histone methylation | 11.19% (16/143) | 3.44 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 13.99% (20/143) | 2.83 | 0.0 | 0.0 |
GO:0032259 | methylation | 13.29% (19/143) | 2.86 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 13.29% (19/143) | 2.86 | 0.0 | 0.0 |
GO:0040029 | regulation of gene expression, epigenetic | 9.09% (13/143) | 3.64 | 0.0 | 0.0 |
GO:0005634 | nucleus | 60.14% (86/143) | 0.84 | 0.0 | 0.0 |
GO:0045814 | negative regulation of gene expression, epigenetic | 8.39% (12/143) | 3.71 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 10.49% (15/143) | 3.09 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 32.17% (46/143) | 1.37 | 0.0 | 0.0 |
GO:0031507 | heterochromatin assembly | 7.69% (11/143) | 3.62 | 0.0 | 0.0 |
GO:0070828 | heterochromatin organization | 7.69% (11/143) | 3.61 | 0.0 | 0.0 |
GO:0006275 | regulation of DNA replication | 6.99% (10/143) | 3.85 | 0.0 | 0.0 |
GO:0018193 | peptidyl-amino acid modification | 10.49% (15/143) | 2.85 | 0.0 | 0.0 |
GO:0000910 | cytokinesis | 7.69% (11/143) | 3.48 | 0.0 | 0.0 |
GO:0006325 | chromatin organization | 8.39% (12/143) | 3.16 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 16.78% (24/143) | 1.86 | 0.0 | 2e-06 |
GO:0000911 | cytokinesis by cell plate formation | 6.99% (10/143) | 3.37 | 0.0 | 2e-06 |
GO:0010605 | negative regulation of macromolecule metabolic process | 11.19% (16/143) | 2.34 | 0.0 | 4e-06 |
GO:0010629 | negative regulation of gene expression | 9.09% (13/143) | 2.67 | 0.0 | 5e-06 |
GO:0043170 | macromolecule metabolic process | 34.27% (49/143) | 1.06 | 0.0 | 5e-06 |
GO:0031048 | heterochromatin assembly by small RNA | 5.59% (8/143) | 3.75 | 0.0 | 5e-06 |
GO:0008283 | cell population proliferation | 6.29% (9/143) | 3.43 | 0.0 | 5e-06 |
GO:0009892 | negative regulation of metabolic process | 11.19% (16/143) | 2.27 | 0.0 | 7e-06 |
GO:0090304 | nucleic acid metabolic process | 19.58% (28/143) | 1.55 | 0.0 | 7e-06 |
GO:0006346 | DNA methylation-dependent heterochromatin assembly | 5.59% (8/143) | 3.62 | 0.0 | 8e-06 |
GO:0009059 | macromolecule biosynthetic process | 16.78% (24/143) | 1.67 | 0.0 | 1.2e-05 |
GO:0016458 | obsolete gene silencing | 4.2% (6/143) | 4.32 | 1e-06 | 1.4e-05 |
GO:0016572 | histone phosphorylation | 4.2% (6/143) | 4.23 | 1e-06 | 2.1e-05 |
GO:0043229 | intracellular organelle | 79.72% (114/143) | 0.39 | 1e-06 | 2.2e-05 |
GO:0043226 | organelle | 79.72% (114/143) | 0.39 | 1e-06 | 2.2e-05 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 4.2% (6/143) | 4.18 | 1e-06 | 2.3e-05 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 4.2% (6/143) | 4.18 | 1e-06 | 2.3e-05 |
GO:0006270 | DNA replication initiation | 4.2% (6/143) | 4.16 | 1e-06 | 2.3e-05 |
GO:0007346 | regulation of mitotic cell cycle | 4.9% (7/143) | 3.73 | 1e-06 | 2.3e-05 |
GO:0043231 | intracellular membrane-bounded organelle | 79.02% (113/143) | 0.4 | 1e-06 | 2.3e-05 |
GO:0043227 | membrane-bounded organelle | 79.02% (113/143) | 0.4 | 1e-06 | 2.3e-05 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 4.2% (6/143) | 4.05 | 2e-06 | 3.5e-05 |
GO:0042023 | DNA endoreduplication | 4.9% (7/143) | 3.61 | 2e-06 | 3.6e-05 |
GO:0044786 | cell cycle DNA replication | 4.9% (7/143) | 3.6 | 2e-06 | 3.8e-05 |
GO:1901987 | regulation of cell cycle phase transition | 4.2% (6/143) | 3.99 | 2e-06 | 4.2e-05 |
GO:0006974 | cellular response to DNA damage stimulus | 6.99% (10/143) | 2.71 | 3e-06 | 6.2e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 20.98% (30/143) | 1.27 | 5e-06 | 8.3e-05 |
GO:0000226 | microtubule cytoskeleton organization | 6.29% (9/143) | 2.86 | 5e-06 | 8.3e-05 |
GO:0006281 | DNA repair | 6.29% (9/143) | 2.81 | 6e-06 | 0.00011 |
GO:0048449 | floral organ formation | 4.9% (7/143) | 3.27 | 9e-06 | 0.000146 |
GO:0007017 | microtubule-based process | 6.29% (9/143) | 2.75 | 9e-06 | 0.000149 |
GO:0006464 | cellular protein modification process | 15.38% (22/143) | 1.51 | 9e-06 | 0.000152 |
GO:0036211 | protein modification process | 15.38% (22/143) | 1.51 | 9e-06 | 0.000152 |
GO:0010564 | regulation of cell cycle process | 4.9% (7/143) | 3.24 | 1e-05 | 0.00016 |
GO:0046483 | heterocycle metabolic process | 22.38% (32/143) | 1.15 | 1.3e-05 | 0.000205 |
GO:0034641 | cellular nitrogen compound metabolic process | 23.08% (33/143) | 1.11 | 1.6e-05 | 0.000252 |
GO:0006302 | double-strand break repair | 4.2% (6/143) | 3.48 | 1.7e-05 | 0.000264 |
GO:0000280 | nuclear division | 3.5% (5/143) | 3.94 | 1.9e-05 | 0.000287 |
GO:0097472 | cyclin-dependent protein kinase activity | 2.8% (4/143) | 4.6 | 2.2e-05 | 0.000322 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 2.8% (4/143) | 4.6 | 2.2e-05 | 0.000322 |
GO:0006305 | DNA alkylation | 4.9% (7/143) | 2.98 | 3.2e-05 | 0.000448 |
GO:0006306 | DNA methylation | 4.9% (7/143) | 2.98 | 3.2e-05 | 0.000448 |
GO:0044728 | DNA methylation or demethylation | 4.9% (7/143) | 2.97 | 3.4e-05 | 0.000475 |
GO:0006304 | DNA modification | 4.9% (7/143) | 2.96 | 3.5e-05 | 0.000479 |
GO:0048519 | negative regulation of biological process | 12.59% (18/143) | 1.58 | 3.5e-05 | 0.000481 |
GO:1905393 | plant organ formation | 4.9% (7/143) | 2.8 | 7e-05 | 0.00094 |
GO:0043412 | macromolecule modification | 16.08% (23/143) | 1.27 | 7.2e-05 | 0.000958 |
GO:0051225 | spindle assembly | 2.8% (4/143) | 4.07 | 9.4e-05 | 0.001232 |
GO:0006725 | cellular aromatic compound metabolic process | 22.38% (32/143) | 1.0 | 9.9e-05 | 0.00128 |
GO:0009909 | regulation of flower development | 6.29% (9/143) | 2.29 | 0.000103 | 0.001308 |
GO:0044267 | cellular protein metabolic process | 16.08% (23/143) | 1.23 | 0.000113 | 0.001376 |
GO:0140694 | non-membrane-bounded organelle assembly | 2.8% (4/143) | 4.01 | 0.000112 | 0.001383 |
GO:0007051 | spindle organization | 2.8% (4/143) | 4.01 | 0.000112 | 0.001383 |
GO:0070925 | organelle assembly | 2.8% (4/143) | 3.98 | 0.000121 | 0.001462 |
GO:0007010 | cytoskeleton organization | 6.29% (9/143) | 2.25 | 0.000124 | 0.001464 |
GO:0010212 | response to ionizing radiation | 3.5% (5/143) | 3.38 | 0.000124 | 0.001481 |
GO:0048285 | organelle fission | 3.5% (5/143) | 3.35 | 0.000137 | 0.001598 |
GO:0048831 | regulation of shoot system development | 6.29% (9/143) | 2.23 | 0.000143 | 0.001648 |
GO:0048580 | regulation of post-embryonic development | 6.99% (10/143) | 2.03 | 0.00019 | 0.002132 |
GO:0031047 | gene silencing by RNA | 4.2% (6/143) | 2.86 | 0.00019 | 0.002155 |
GO:2000026 | regulation of multicellular organismal development | 6.99% (10/143) | 2.01 | 0.00021 | 0.00233 |
GO:0060255 | regulation of macromolecule metabolic process | 18.18% (26/143) | 1.07 | 0.000234 | 0.002568 |
GO:0006310 | DNA recombination | 4.9% (7/143) | 2.51 | 0.000242 | 0.002623 |
GO:0006807 | nitrogen compound metabolic process | 30.77% (44/143) | 0.74 | 0.000253 | 0.002709 |
GO:1901360 | organic cyclic compound metabolic process | 22.38% (32/143) | 0.92 | 0.000258 | 0.002732 |
GO:1903046 | meiotic cell cycle process | 4.9% (7/143) | 2.48 | 0.000282 | 0.002953 |
GO:0006996 | organelle organization | 11.89% (17/143) | 1.36 | 0.000343 | 0.003555 |
GO:0044237 | cellular metabolic process | 38.46% (55/143) | 0.6 | 0.000349 | 0.003583 |
GO:0051239 | regulation of multicellular organismal process | 6.99% (10/143) | 1.9 | 0.000383 | 0.003895 |
GO:2000241 | regulation of reproductive process | 6.29% (9/143) | 2.02 | 0.000402 | 0.004046 |
GO:0016246 | RNA interference | 2.8% (4/143) | 3.51 | 0.000432 | 0.004296 |
GO:0022414 | reproductive process | 16.78% (24/143) | 1.06 | 0.000469 | 0.004618 |
GO:0000808 | origin recognition complex | 1.4% (2/143) | 5.79 | 0.000548 | 0.004991 |
GO:0016043 | cellular component organization | 17.48% (25/143) | 1.01 | 0.000556 | 0.005017 |
GO:0050789 | regulation of biological process | 27.97% (40/143) | 0.74 | 0.000516 | 0.005032 |
GO:0033044 | regulation of chromosome organization | 3.5% (5/143) | 2.92 | 0.000548 | 0.005032 |
GO:0051128 | regulation of cellular component organization | 4.9% (7/143) | 2.31 | 0.000565 | 0.005048 |
GO:0009294 | DNA mediated transformation | 2.1% (3/143) | 4.23 | 0.000547 | 0.005078 |
GO:0009292 | genetic transfer | 2.1% (3/143) | 4.23 | 0.000547 | 0.005078 |
GO:0044764 | multi-organism cellular process | 2.1% (3/143) | 4.23 | 0.000547 | 0.005078 |
GO:0048453 | sepal formation | 2.8% (4/143) | 3.43 | 0.000537 | 0.005129 |
GO:0048451 | petal formation | 2.8% (4/143) | 3.43 | 0.000537 | 0.005129 |
GO:0051052 | regulation of DNA metabolic process | 2.8% (4/143) | 3.37 | 0.000627 | 0.005498 |
GO:0010332 | response to gamma radiation | 2.8% (4/143) | 3.37 | 0.000627 | 0.005498 |
GO:0035194 | post-transcriptional gene silencing by RNA | 2.8% (4/143) | 3.31 | 0.000727 | 0.006318 |
GO:0005515 | protein binding | 15.38% (22/143) | 1.05 | 0.000918 | 0.00791 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 4.9% (7/143) | 2.15 | 0.00106 | 0.009049 |
GO:0051276 | chromosome organization | 4.2% (6/143) | 2.35 | 0.001201 | 0.01017 |
GO:0016441 | posttranscriptional gene silencing | 3.5% (5/143) | 2.65 | 0.001257 | 0.01055 |
GO:0000278 | mitotic cell cycle | 3.5% (5/143) | 2.58 | 0.001572 | 0.01308 |
GO:0019222 | regulation of metabolic process | 18.18% (26/143) | 0.88 | 0.001608 | 0.013153 |
GO:0050794 | regulation of cellular process | 23.78% (34/143) | 0.74 | 0.001599 | 0.013186 |
GO:0019538 | protein metabolic process | 17.48% (25/143) | 0.89 | 0.001782 | 0.014448 |
GO:0071704 | organic substance metabolic process | 37.76% (54/143) | 0.52 | 0.00181 | 0.014555 |
GO:0140096 | catalytic activity, acting on a protein | 11.89% (17/143) | 1.14 | 0.001905 | 0.015065 |
GO:0071840 | cellular component organization or biogenesis | 17.48% (25/143) | 0.89 | 0.001897 | 0.015132 |
GO:0071514 | genetic imprinting | 1.4% (2/143) | 4.89 | 0.001995 | 0.015159 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.4% (2/143) | 4.89 | 0.001995 | 0.015159 |
GO:0061982 | meiosis I cell cycle process | 2.8% (4/143) | 2.92 | 0.001968 | 0.015192 |
GO:0033043 | regulation of organelle organization | 3.5% (5/143) | 2.51 | 0.001942 | 0.015236 |
GO:0050793 | regulation of developmental process | 8.39% (12/143) | 1.41 | 0.001959 | 0.015247 |
GO:1990234 | transferase complex | 4.2% (6/143) | 2.19 | 0.002121 | 0.01599 |
GO:0004674 | protein serine/threonine kinase activity | 4.9% (7/143) | 1.96 | 0.002284 | 0.016956 |
GO:0065007 | biological regulation | 28.67% (41/143) | 0.62 | 0.002279 | 0.017045 |
GO:0008152 | metabolic process | 39.86% (57/143) | 0.48 | 0.002356 | 0.017352 |
GO:0045132 | meiotic chromosome segregation | 2.8% (4/143) | 2.84 | 0.002423 | 0.017716 |
GO:0140097 | catalytic activity, acting on DNA | 2.8% (4/143) | 2.83 | 0.002506 | 0.018045 |
GO:0098813 | nuclear chromosome segregation | 2.8% (4/143) | 2.83 | 0.002506 | 0.018045 |
GO:0009957 | epidermal cell fate specification | 1.4% (2/143) | 4.69 | 0.002668 | 0.019068 |
GO:0001708 | cell fate specification | 2.1% (3/143) | 3.37 | 0.003071 | 0.021792 |
GO:0006312 | mitotic recombination | 2.1% (3/143) | 3.35 | 0.00323 | 0.02275 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 4.9% (7/143) | 1.85 | 0.003503 | 0.024495 |
GO:0044249 | cellular biosynthetic process | 20.98% (30/143) | 0.73 | 0.003531 | 0.024513 |
GO:0006468 | protein phosphorylation | 5.59% (8/143) | 1.69 | 0.003642 | 0.025105 |
GO:0051704 | multi-organism process | 2.1% (3/143) | 3.27 | 0.003735 | 0.025562 |
GO:0007140 | male meiotic nuclear division | 1.4% (2/143) | 4.35 | 0.004286 | 0.028921 |
GO:0140013 | meiotic nuclear division | 1.4% (2/143) | 4.35 | 0.004286 | 0.028921 |
GO:0007059 | chromosome segregation | 2.8% (4/143) | 2.6 | 0.004456 | 0.029864 |
GO:0090241 | negative regulation of histone H4 acetylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0015350 | methotrexate transmembrane transporter activity | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0006887 | exocytosis | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0015231 | 5-formyltetrahydrofolate transmembrane transporter activity | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0000012 | single strand break repair | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0008618 | 7-methylguanosine metabolic process | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0043987 | histone H3-S10 phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0098763 | mitotic cell cycle phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:2000114 | regulation of establishment of cell polarity | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0007063 | regulation of sister chromatid cohesion | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0032196 | transposition | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0003688 | DNA replication origin binding | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0032197 | transposition, RNA-mediated | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0045876 | positive regulation of sister chromatid cohesion | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0000279 | M phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0051958 | methotrexate transport | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0000087 | mitotic M phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0043988 | histone H3-S28 phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0044022 | histone kinase activity (H3-S28 specific) | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0035404 | histone-serine phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.029879 |
GO:0003713 | transcription coactivator activity | 1.4% (2/143) | 4.2 | 0.005228 | 0.030029 |
GO:0140527 | reciprocal homologous recombination | 2.8% (4/143) | 2.51 | 0.005518 | 0.031323 |
GO:0007131 | reciprocal meiotic recombination | 2.8% (4/143) | 2.51 | 0.005518 | 0.031323 |
GO:0007049 | cell cycle | 3.5% (5/143) | 2.14 | 0.005715 | 0.032251 |
GO:0035825 | homologous recombination | 2.8% (4/143) | 2.49 | 0.005808 | 0.032584 |
GO:0110165 | cellular anatomical entity | 92.31% (132/143) | 0.12 | 0.0051 | 0.033944 |
GO:0007062 | sister chromatid cohesion | 2.8% (4/143) | 2.46 | 0.006261 | 0.034923 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.5% (5/143) | 2.09 | 0.006629 | 0.036765 |
GO:0007129 | homologous chromosome pairing at meiosis | 2.1% (3/143) | 2.86 | 0.00832 | 0.045879 |
GO:0004799 | thymidylate synthase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0051307 | meiotic chromosome separation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0051304 | chromosome separation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0018105 | peptidyl-serine phosphorylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0000281 | mitotic cytokinesis | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0018209 | peptidyl-serine modification | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0010069 | zygote asymmetric cytokinesis in embryo sac | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0005640 | nuclear outer membrane | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0004146 | dihydrofolate reductase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0070182 | DNA polymerase binding | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0006271 | DNA strand elongation involved in DNA replication | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0000798 | nuclear cohesin complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0004671 | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0006481 | C-terminal protein methylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0022616 | DNA strand elongation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0000729 | DNA double-strand break processing | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0052381 | tRNA dimethylallyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0009257 | 10-formyltetrahydrofolate biosynthetic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0009256 | 10-formyltetrahydrofolate metabolic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0000706 | meiotic DNA double-strand break processing | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0035102 | PRC1 complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0018410 | C-terminal protein amino acid modification | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0090239 | regulation of histone H4 acetylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.048557 |
GO:0003712 | transcription coregulator activity | 1.4% (2/143) | 3.69 | 0.010505 | 0.049211 |